Prenatal Exposure to Phentermine-Topiramate Lower Under Safety Program
TUESDAY, March 21, 2023 -- Under the Risk Evaluation and Mitigation Strategy (REMS), prenatal exposure to phentermine-topiramate is lower than topiramate and other antiobesity medications (AOMs), according to a study published online March 21 in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2023 Category: Pharmaceuticals Source Type: news
Ozempic Back on Shelves; More Positive Fezolinetant Data; Caffeine Cuts Fat?
(MedPage Today) -- After major shortages of semaglutide (Ozempic), the 0.25 mg, 0.5 mg, and 1 mg doses are back on shelves. The 2 mg dose still has limited availability until the end of March. (Reuters)
Prenatal exposure to phentermine-topiramate... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - March 21, 2023 Category: Endocrinology Source Type: news
FDA Expands Use of Weight-Loss Drug to Adolescents
(MedPage Today) -- The FDA approved a supplemental indication for phentermine/topiramate extended-release capsules (Qsymia) for chronic weight management in adolescents ages 12 and older with obesity, defined as a body mass index (BMI) in the 95th... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - June 28, 2022 Category: American Health Source Type: news
FDA approves treatment for chronic weight management in pediatric patients aged 12 years and older
The U.S. Food and Drug Administration has approved a supplemental indication for Qsymia (phentermine and topiramate extended-release capsules) for chronic weight management in pediatric patients aged 12 years and older who are obese, defined as a body mass index (BMI) of 95th percentile or greater w (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 27, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news
FDA Approves Qsymia for Chronic Weight Management in Certain Pediatric Patients Aged 12 years and Older
June 27, 2022 -- The U.S. Food and Drug Administration has approved a supplemental indication for Qsymia (phentermine and topiramate extended-release capsules) for chronic weight management in pediatric patients aged 12 years and older who are... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 27, 2022 Category: Drugs & Pharmacology Source Type: news
Is Phentermine/Topiramate Helpful After Teen Bariatric Surgery? Is Phentermine/Topiramate Helpful After Teen Bariatric Surgery?
' We do not yet know what the optimal dose or postoperative timing of phentermine/topiramate (or any other anti-obesity medication) is after bariatric surgery in adolescents, ' says the author of a pilot study.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 15, 2021 Category: Cardiology Tags: General Surgery News Source Type: news
Antiobesity Meds May Curb Weight Regain After RYGB
FRIDAY, May 22, 2020 -- The antiobesity medications (AOMs) phentermine and topiramate may help mitigate weight regain (WR) after Roux-en-Y gastric bypass (RYGB) surgery, according to a study published online May 22 in Obesity.
Nawfal W. Istfan,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 22, 2020 Category: Pharmaceuticals Source Type: news
Long-Term Phentermine Use Safe, Effective for Weight Loss
FRIDAY, March 29, 2019 -- Patients taking phentermine for weight loss for more than three months experience greater weight loss without an increased risk for incident cardiovascular disease or death, according to a study published online March 21 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 29, 2019 Category: Pharmaceuticals Source Type: news
Phentermine for weight loss
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - January 17, 2019 Category: Consumer Health News Source Type: news
Long-Term Phentermine for Weight Loss Appears Safe, Effective Long-Term Phentermine for Weight Loss Appears Safe, Effective
Retrospective study not definitive, but lends support to extending use of the generic commonly used obesity drug beyond the short-term label indication.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 15, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
Ionamin (Phentermine Capsules) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 4, 2017 Category: Drugs & Pharmacology Source Type: news
Suprenza (phentermine hydrochloride) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 3, 2017 Category: Drugs & Pharmacology Source Type: news
Qsymia (Phentermine and Topiramate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 6, 2017 Category: Drugs & Pharmacology Source Type: news
Fastin (Phentermine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 26, 2017 Category: Drugs & Pharmacology Source Type: news
Bucks company's weight-reduction pill gets FDA approval
The Food and Drug Administration has approved a Bucks County company ’s prescription weight reduction medicine, a low-dose and low-cost formulation of phentermine hydrochloride. Here are the details:
Company: KVK Tech, a Newtown-based manufacturer of prescription and over-the-counter medicines.
Product: Lomaira
Approved as: An adjunct therapy for use over a shor t period of time for weight reduction in adults with an initial body mass index of 30 or more, or a body mass index of 27 or more with… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 27, 2016 Category: Biotechnology Authors: John George Source Type: news
